Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anlotinib and Irinotecan in Pretreated Advanced Colorectal Cancer
NCT03545711Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- May 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlotinib in colorectal cancer (CRC), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
anlotinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03545711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03545711.